Listed

CVS HEALTH Corp: Form 10-Q for the period ended Mar 31, 2016

Filed with the SEC on May 3, 2016 and accepted by EDGAR at May 3, 2016, 16:48 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2016-01-01 to 2016-03-31$43.22bnus-gaap:Revenues
Cost of revenue3 months2016-01-01 to 2016-03-31$36.47bnus-gaap:CostOfRevenue
Gross profit3 months2016-01-01 to 2016-03-31$6.74bnus-gaap:GrossProfit
Operating income3 months2016-01-01 to 2016-03-31$2.18bnus-gaap:OperatingIncomeLoss
Interest expense3 months2016-01-01 to 2016-03-31$288.0mus-gaap:InterestExpense
Income tax3 months2016-01-01 to 2016-03-31$746.0mus-gaap:IncomeTaxExpenseBenefit
Diluted EPS3 months2016-01-01 to 2016-03-31$1.04us-gaap:EarningsPerShareDiluted
Basic EPS3 months2016-01-01 to 2016-03-31$1.04us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2016-01-01 to 2016-03-311,099,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2016-01-01 to 2016-03-31$2.41bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2016-01-01 to 2016-03-31$598.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid3 months2016-01-01 to 2016-03-31$470.0mus-gaap:PaymentsOfDividends
Share repurchases3 months2016-01-01 to 2016-03-31$2.07bnus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2016-03-31$1.78bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-03-31$29.41bnus-gaap:AssetsCurrent
Total assetsAt period end2016-03-31$92.63bnus-gaap:Assets
Current liabilitiesAt period end2016-03-31$24.54bnus-gaap:LiabilitiesCurrent
Shareholders' equityAt period end2016-03-31$36.02bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000064803-16-000080. Last ingested by Listed: Nov 6, 2026, 17:47 ET. Listed shows no prices and gives no investment advice.